SCHEDULE 13G/A: AIGH Capital Management and Orin Hirschman Disclose Significant Passive Stake in Coya Therapeutics
Beneficial Ownership Disclosure
AIGH Capital Management LLC and Orin Hirschman have filed an amended Schedule 13G, disclosing their combined passive beneficial ownership of 8% of Coya Therapeutics, Inc.'s common stock as of December 31, 2024.
Summary
- Orin Hirschman and AIGH Capital Management LLC, along with AIGH Investment Partners LLC, jointly filed an amended Schedule 13G regarding their holdings in Coya Therapeutics, Inc.
- As of December 31, 2024, Orin Hirschman beneficially owns 1,333,919 shares of Coya Therapeutics, Inc. common stock, representing 8% of the class.
- AIGH Capital Management LLC beneficially owns 1,201,152 shares, representing 7.2% of the class.
- The filing explicitly states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Coya Therapeutics, Inc.
- Orin Hirschman's reported beneficial ownership excludes 280,000 common shares issuable upon the exercise of warrants, which are currently not exercisable due to beneficial ownership limitations.
Sentiment
Score: 5
Explanation: The filing is a standard disclosure of passive beneficial ownership and does not contain information that would significantly alter the sentiment towards the company's operational or financial performance.
Positives
- AIGH Capital Management and Orin Hirschman maintain a significant stake in Coya Therapeutics, indicating continued confidence in the company as a passive investment.
- The explicit statement that the investment is for ordinary course of business and not for control purposes may signal stability for the company's current management and strategic direction.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: Provides transparency regarding significant passive ownership stakes in the company.
- Company Management: Confirms that a significant investor is not seeking to influence control, potentially reducing concerns about activist pressure.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which requires filing of this statement (snapshot of beneficial ownership) |
| 02/10/2025 | Date of filing of this statement |
Keywords
Coya Therapeutics, AIGH Capital Management, Orin Hirschman, Schedule 13G, SEC filing, beneficial ownership, common stock, investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.